Table 1.
Molar Ratio of Components Used in All Liposomal Formulations
| Sample | HSPC | Chol | DSPE-PEG | DSPE-PEG- AE147 | DSPE-PEG- FITC | DSPE-PEG- Ce6 |
|---|---|---|---|---|---|---|
| Lipo | 11 | 8 | 1 | – | – | – |
| AE-Lipo | 11 | 8 | 0.5 | 0.5 | – | – |
| FITC-Lipo | 11 | 8 | 1 | – | 0.2 | – |
| FITC-AE-Lipo | 11 | 8 | 0.5 | 0.5 | 0.2 | – |
| Ce6-Lipo | 11 | 8 | 1 | – | – | 1 |
| Ce6-AE-Lipo | 11 | 8 | – | 1 | – | 1 |
Abbreviations: Chol, cholesterol; Lipo, non-targeting liposomes; AE-Lipo, targeting liposomes; FITC-Lipo, FITC-conjugated Lipo; FITC-AE-Lipo, FITC-conjugated AE-Lipo; Ce6-Lipo, Ce6-conjugated Lipo; Ce6-AE-Lipo, Ce6-conjugated AE-Lipo.